tech
April 15, 2026
Max Hodak’s Science Corp. is preparing to place its first sensor in a human brain
The device could help address multiple neurological conditions if it proves successful. One early use could be delivering gentle electrical stimulation to damaged brain or spinal cord cells to encourage healing.
TL;DR
- Science Corporation, co-founded by Max Hodak, is initiating U.S. human trials for its biohybrid brain-computer interface.
- Dr. Murat Günel, chair of Neurosurgery at Yale Medical School, will lead the placement of the first sensor, which combines lab-grown neurons with electronics.
- The company's advanced product, PRIMA, is already in clinical trials for vision restoration.
- Hodak's broader vision involves creating communication links between computers and the human brain for treatment and enhancement.
- Science's approach uses lab-grown neurons that integrate biologically with the brain, unlike conventional electrode-based methods that can cause damage.
- The initial trials will test the sensor, without embedded neurons, on patients already undergoing significant brain surgery.
- Potential applications include stimulating damaged cells for healing, monitoring neurological activity, and treating conditions like Parkinson's disease by potentially stopping disease progression.
Continue reading the original article